Bristol Myers Squibb said it will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer’s disease, after the company found “irregularities due to ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO International Convention from June 16-19 in Boston, where key executives, including CEO Georg Ng and President of R&D Dr.

ARLINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (Nasdaq:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...

HAYWARD, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Aarvik Therapeutics announces a global license and assignment Agreement with NJ Bio, Inc. to secure a class of novel proprietary payloads with a ...

BridgeBio jumps on major clinical wins, strong launches and rare-disease programs targeting large markets with new drugs ...

Lyric Bio is developing a next-generation biomanufacturing platform for IVIg production. The company’s approach uses tissue-mimicking bioreactors built on a proprietary laser-printed cellular ...

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( ($HK:1349) ) just unveiled an update. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Ironwood Pharma remains undervalued despite a failed $1bn Vectiv Bio acquisition and subsequent stock plunge, with Linzess ...

ORLEANS, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“Tetra” or the “Company”) (TSX VENTURE: TBP) (OTCQB: TBPMF), a leader in cannabinoid-based drug discovery and development has ...

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( ($HK:1349) ) has provided an update. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has ...

The Bio/Pharmaceutical Outsourcing Report is an essential monthly resource that delves into the dynamic landscape of pharmaceutical Contract Manufacturing Organizations (CMOs). This report scrutinizes ...

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association held a board meeting on the 15th and announced the appointment of Lee Jae-guk as the next vice chairman and other full-time executives ...